Back to News
Market Impact: 0.3
Harmony Biosciences Holdings, Inc. (HRMY) Q3 Earnings and Revenues Lag Estimates
Source: zacks.com
Corporate EarningsAnalyst EstimatesCompany Fundamentals
Harmony Biosciences reported quarterly earnings of $0.81 per share, missing the Zacks consensus estimate of $1.00 by $0.19, or 19%. Earnings were down from $0.87 per share a year earlier.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.35
Ticker Sentiment
HRMY-0.65
More News
- NextDC shares surge 43% after Goodman, Digital Realty stake purchases
- A blue wave sends futures into the green
- Asian chip stocks slide as disappointing Qualcomm, Arm earnings weigh
- Snap shares fall over 10% on third-quarter earnings miss
- ‘Seismic’ blue wave triggers the sinking of oil prices, energy stocks, and the chances of power permitting reform
- Softbank’s $5.4 bln takeover of ABB robotics unit blocked by China- FT